Medicomp Unveils New AI Tools for Clinically Validated Intelligence

Healthcare organizations can now deploy reliable, clinically grounded AI capabilities at scale.

Published on Feb. 11, 2026

Got story updates? Submit your updates here. ›

Medicomp Systems, a leading provider of evidence-based clinically intelligent data solutions, has announced a new suite of intelligence tools designed to help health tech organizations deploy reliable, clinically grounded AI capabilities at scale. The announcement comes ahead of industry conferences where Medicomp will preview AI-enabled enhancements across its product offering.

Why it matters

Healthcare organizations are increasingly struggling to manage inaccurate, incomplete, or poorly structured clinical data entering the medical record, particularly when AI-generated output is accessed and saved without validation. Medicomp's updated AI strategy is designed to close the clinical context gap by embedding clinical validation directly into AI-enabled workflows, helping ensure patient safety, compliance, analytics, and interoperability.

The details

Medicomp's strategy enhances both existing and future products using a combination of LLM technologies and the company's universal structured data foundation, patented clinical knowledge graph, and relevancy engine. This allows health technologies to embrace responsible AI and deliver transparency, consistency, and clinical relevance rather than opaque or probabilistic approaches. Core elements include clinically validating output from conversational and ambient listening technologies, tools to recall and manipulate data using natural language, and intelligent NLP to convert narrative text into trustworthy structured clinical data.

  • Medicomp will preview the new AI-enabled functionality at ViVE 2026 (booth 2329) and HIMSS 2026 (booth 5435) in February 2026.
  • Select new capabilities are live and in use by customers today, with continued expansion planned throughout 2026 and beyond.

The players

Medicomp Systems

A leading provider of evidence-based clinically intelligent data solutions.

David Lareau

President and CEO of Medicomp Systems.

Got photos? Submit your photos here. ›

What they’re saying

“Healthcare organizations are increasingly focused on advancing AI from isolated use cases into reliable, enterprise-ready capabilities. Our approach is to enable such innovation while preserving clinical integrity, accuracy, and trust. By validating data at the point it is created or exchanged, we help ensure that AI-powered workflows are built on information clinicians and organizations can rely on.”

— David Lareau, President and CEO (PRNewswire)

What’s next

Medicomp will offer live previews and demonstrations of its AI-enabled functionality and roadmap at ViVE 2026 and HIMSS 2026, and recommends reserving and scheduling the demo time in advance.

The takeaway

Medicomp's new AI-enablement tools aim to help healthcare organizations deploy reliable, clinically validated AI capabilities that preserve data integrity, accuracy, and trust, addressing the growing challenge of managing inaccurate or poorly structured clinical data entering the medical record.